Chronic pain that persists despite traditional pain management creates cycles of suffering that impact every dimension of life. At Mend The Mind, we provide specialized ketamine therapy for chronic pain conditions including fibromyalgia, neuropathic pain, complex regional pain syndrome, and other pain syndromes that haven’t responded to conventional treatments. Our approach addresses both the neurological mechanisms maintaining chronic pain and the psychological toll of living with persistent suffering.
Chronic pain persists beyond normal healing timeframes, typically lasting three months or longer. Unlike acute pain signaling tissue damage requiring attention, chronic pain often continues after initial injuries heal or develops without clear physical cause. The pain becomes the disease itself rather than a symptom of underlying injury.
Several mechanisms drive chronic pain persistence. Central sensitization occurs when your nervous system becomes hypersensitive, amplifying pain signals and triggering pain from normally non-painful stimuli. This “wind-up” phenomenon creates a persistent state of high reactivity where even light touch or normal movement causes severe pain. Neuroplastic changes reshape pain pathways in your brain and spinal cord, reinforcing pain patterns through repeated activation. Inflammatory processes in the nervous system maintain pain signals long after initial triggers resolve.
Common chronic pain conditions we treat include fibromyalgia, which causes widespread musculoskeletal pain with tender points, fatigue, and cognitive difficulties. Neuropathic pain results from nerve damage or dysfunction, creating burning, shooting, or electric-shock sensations. Complex regional pain syndrome produces intense pain disproportionate to initial injury, often with swelling, temperature changes, and skin sensitivity. Chronic back pain, migraines, and other persistent pain conditions also respond to ketamine therapy when conventional treatments fail.
The psychological impact of chronic pain compounds physical suffering. Depression develops in 30-50% of chronic pain patients, anxiety about pain flares creates hypervigilance and tension, sleep disruption from pain and worry worsens everything, and social isolation increases as pain limits activities and relationships. This mind-body interaction means effective chronic pain treatment must address both neurological and psychological dimensions.
Traditional pain management focuses on opioids, anti-inflammatory medications, antidepressants, anticonvulsants, and interventional procedures. These approaches help many patients but leave 30-40% with inadequate relief. Several factors complicate chronic pain treatment.
Opioids provide pain relief but carry addiction risk, tolerance requiring ever-higher doses, and hyperalgesia where long-term use paradoxically increases pain sensitivity. The opioid crisis has appropriately made prescribers cautious, yet this leaves some patients with severe pain undertreated. NSAIDs and other anti-inflammatory drugs lose effectiveness over time and cause gastrointestinal, cardiovascular, and kidney problems with prolonged use.
Nerve blocks, ablations, spinal cord stimulation, and other interventional procedures work for some pain types but not others, and benefits often diminish over months to years. Physical therapy requires pain levels low enough to participate, creating catch-22 situations where pain prevents the movement needed for improvement.
The emotional exhaustion of failed treatment after failed treatment creates learned helplessness and hopelessness. Many chronic pain patients have tried dozens of approaches over years or decades without sustained relief. This treatment fatigue makes it difficult to maintain hope that anything will help.
Ketamine addresses chronic pain through mechanisms distinct from traditional pain medications. As an NMDA receptor antagonist, ketamine blocks the receptors mediating central sensitization and pain pathway neuroplasticity. This interrupts the “wind-up” phenomenon maintaining chronic pain states, essentially resetting hypersensitive pain processing.
Ketamine demonstrates particular effectiveness for neuropathic pain that responds poorly to opioids. It reduces inflammatory markers in the nervous system, including TNF-alpha and other cytokines maintaining neuroinflammation. The medication enhances brain-derived neurotrophic factor, promoting neuroplasticity that can reshape maladaptive pain pathways. Ketamine also reduces activity in the brain’s default mode network, disrupting rumination patterns that amplify pain perception.
For chronic pain management, ketamine infusions typically run longer than mental health protocols—often 2-4 hours depending on your condition and response. This extended infusion time allows sustained receptor blockade necessary for pain pathway modulation. The anesthesia-level monitoring we provide ensures safety throughout these longer sessions.
Research evidence supports ketamine for multiple chronic pain conditions. Studies in fibromyalgia show significant VAS pain score reductions following ketamine infusions, though effects vary between individuals and may require repeated treatments. Neuropathic pain from nerve damage, diabetic neuropathy, or post-herpetic neuralgia responds well to ketamine’s NMDA receptor blockade. Complex regional pain syndrome, notoriously difficult to treat, often improves with ketamine infusions when other interventions fail.
The pain relief ketamine provides often extends well beyond the infusion itself. Many patients experience reduced pain lasting days to weeks after treatment, with cumulative benefits across multiple sessions. This suggests ketamine isn’t just blocking pain signals temporarily but helping reorganize pain processing pathways.
Our primary chronic pain treatment uses IV ketamine delivered over 2-4 hours under continuous medical monitoring. Your Board Certified CRNA ensures both therapeutic effectiveness and medical safety throughout extended infusions. Initial protocols typically involve 4-6 infusions scheduled 1-2 times weekly, though chronic pain often requires more individualized scheduling than mental health treatment.
Dosing for chronic pain may differ from depression protocols, with some patients needing higher doses or longer infusion times. We adjust your treatment based on pain levels, side effects, and response patterns. The goal is sustained pain reduction without excessive dissociative effects, though some patients benefit from the altered consciousness allowing different relationships with their pain.
Following initial treatment series, maintenance infusions help sustain benefits. Frequency varies widely—some patients need monthly treatments while others go months between infusions. Your maintenance schedule develops based on how long pain relief lasts and how significantly pain impacts your functioning.
Ketamine works best as part of comprehensive pain management rather than standalone treatment. Our psychiatric medication expertise ensures your pain medications, antidepressants, sleep aids, and other prescriptions work synergistically. We can help you reduce opioid dependence if ketamine provides alternative pain relief, adjust medications as your pain improves, and address depression, anxiety, or sleep problems compounding your pain experience.
Many chronic pain patients benefit from combining ketamine with appropriate long-term medications rather than trying ketamine alone. The integration of treatments addresses pain through multiple mechanisms simultaneously.
When chronic pain intertwines with trauma, stress, or psychological factors, somatic facilitation during ketamine sessions helps address the mind-body dimensions. You’ll work with physical sensations and nervous system regulation during treatment, learning to relate to pain differently and release tension patterns maintaining discomfort.
This approach is particularly valuable for fibromyalgia and other conditions where central sensitization and psychological stress mutually reinforce each other. The body-centered work helps you distinguish pain signals from muscle tension, recognize when anxiety amplifies pain perception, and develop regulation skills reducing pain intensity.
Ketamine’s effectiveness for chronic pain shows more variable results than for depression or PTSD. Some patients experience dramatic pain reduction—50% or more improvement—while others notice modest benefits or no relief. Predicting who will respond remains challenging, though neuropathic pain and CRPS tend to respond better than purely inflammatory or structural pain.
Pain relief timeline differs from mental health benefits. Some patients notice reduced pain during or immediately after infusion, while others require 2-3 treatments before experiencing relief. Maximum benefits often emerge across the full initial series rather than from single infusions.
The evidence base for ketamine in chronic pain is smaller and less conclusive than for depression. Studies show promise but also highlight significant individual variation in response. We’ll typically know within 4-6 infusions whether ketamine meaningfully helps your specific pain condition.
Realistic expectations matter. Ketamine rarely eliminates chronic pain completely but can reduce intensity enough to improve functioning and quality of life. Even 30-40% pain reduction often allows return to activities, better sleep, reduced medication needs, and improved mood.
You may benefit from ketamine therapy if traditional pain management provides inadequate relief, you have neuropathic pain components, opioids cause problematic side effects or don’t work well, or your pain condition involves central sensitization or neuroplastic changes. Fibromyalgia, CRPS, neuropathic pain from various causes, and chronic pain with significant mood or anxiety components represent ideal applications.
Ketamine is not first-line pain treatment. You should have tried appropriate conventional approaches first including medications specific to your pain type, physical therapy or other rehabilitation, and interventional procedures if indicated for your condition. Ketamine serves best as option for treatment-resistant pain rather than initial intervention.
Medical clearance ensures you’re safe for ketamine treatment. Uncontrolled cardiovascular disease, active substance use disorders, and certain psychiatric conditions require careful evaluation before proceeding.
[1] Vranken, J. H., et al. (2011). “Ketamine for chronic pain: risks and benefits.” British Journal of Clinical Pharmacology, 77(2), 357-367.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014022/
[2] Cohen, S. P., et al. (2018). “Ketamine for the Treatment of Chronic Pain: A Comprehensive Review.” Regional Anesthesia and Pain Medicine, 43(3), 263-283. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567802/
Conditions Treated
1201 U.S. Highway 10 W, Unit A4, Livingston 59047
Mend The Mind is a psychiatric practice in Livingston, Montana, specializing in ketamine therapy and comprehensive mental health services for adults. With anesthesia expertise ensuring the highest safety standards, we bring evidence-based treatment to rural Montana communities.